IP Library Granted Patent US 12,084,666
Granted Patent B2
US 12,084,666 · App. 16/608,146 · Granted Sep 10, 2024

Compositions and methods of dual poison-antidote meiotic drivers

Inventors: Sarah E. Zanders (Prairie Village, KS); Nicole Nuckolls (Shawnee, KS); Maria Angelical Bravo Nunez (Kansas City, KS); Harmit Singh Malik (Shoreline, WA)
Assignees: STOWERS INSTITUTE FOR MEDICAL RESEARCH; FRED HUTCHINSON CANCER CENTER
C12N15/815C07K14/39C12N1/00C12N2800/00C12N2840/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,084,666
App. No.
16/608,146
Granted
Sep 10, 2024
Kind
B2
Abstract

The present disclosure provides, inter alia, meiotic drive genes derived from chromosome 3 of the fission yeasts Schizosaccharomyces kambucha and S. pombe and orthologs thereof. In certain embodiments, compositions, methods, and kits are provided for biasing organisms to express such genes and, optionally, to co-express one or more genes of interest in such organisms.

Claims (25)

1. A meiotic drive composition comprising:

a recombinant DNA sequence encoding a first peptide sequence and a second peptide sequence, the first peptide sequence capable of destroying a gamete and the second peptide sequence capable of rescuing a gamete from the first peptide sequence;

wherein the first peptide sequence is SEQ ID NO: 3;

wherein the second peptide sequence is SEQ ID NO: 4;

wherein the recombinant DNA sequence comprises a heterologous regulatory sequence;

wherein the first peptide sequence is transported outside of a cell and the second peptide sequence is not transported outside of a cell

wherein the first peptide sequence and the second peptide sequence are derived from alternative transcriptional start sites on the recombinant DNA sequence; and

wherein the recombinant DNA sequence, when expressed in a diploid organism, is effective to bias offspring toward having the recombinant DNA.

2. The meiotic drive composition of claim 1 , wherein the recombinant DNA sequence does not naturally occur in the diploid organism.

3. The meiotic drive composition of claim 1 , wherein the recombinant DNA sequence is adapted to integrate into the genome of the diploid organism.

4. A vector comprising the recombinant DNA sequence according to claim 1 , and a heterologous DNA sequence.

5. A meiotic drive composition comprising:

a recombinant DNA sequence encoding a first peptide sequence and a second peptide sequence, the first peptide sequence capable of destroying a gamete and the second peptide sequence capable of rescuing a gamete from the first peptide sequence;

wherein the first peptide sequence is SEQ ID NO: 3;

wherein the second peptide sequence is SEQ ID NO: 4;

wherein the recombinant DNA sequence comprises a heterologous regulatory sequence;

wherein the first peptide sequence is transported outside of a cell and the second peptide sequence is not transported outside of a cell; and

wherein the recombinant DNA sequence, when expressed in a diploid organism, is effective to bias offspring toward having the recombinant DNA.

6. A meiotic drive composition comprising:

a recombinant DNA sequence encoding a first peptide sequence and a second peptide sequence, the first peptide sequence capable of destroying a gamete and the second peptide sequence capable of rescuing a gamete from the first peptide sequence;

wherein the first peptide sequence is SEQ ID NO: 3;

wherein the second peptide sequence is SEQ ID NO: 4;

wherein the recombinant DNA sequence comprises a heterologous regulatory sequence;

wherein the first peptide sequence and the second peptide sequence are derived from alternative transcriptional start sites on the recombinant DNA sequence; and

wherein the recombinant DNA sequence, when expressed in a diploid organism, is effective to bias offspring toward having the recombinant DNA.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jan 26, 2024
From: STOWERS INSTITUTE FRO MEDICAL RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066376/0086 →
MERGER Recorded Apr 26, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060542/0636 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2019
From: ZANDERS, SARAH E.; NUCKOLLS, NICOLE L.; NUNEZ, MARIA ANGELICA BRAVO
To: STOWERS INSTITUTE FOR MEDICAL RESEARCH
Reel/Frame 050821/0357 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2019
From: MALIK, HARMIT SINGH
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 050821/0375 →
Continuity (2)
Provisional Application 62491107 · Apr 27, 2017
Related Publication 20200149054A1 · May 14, 2020